Arrivo BioVentures is actively pursuing products that fulfill the following criteria:
- Offer an improvement to patient care that is both clinically and commercially relevant;
- Have a clear regulatory and development pathway; and
- Have good prospects for achieving a significant development milestone that could support
a sale or partnering transaction within four years of our acquisition of rights.